Modern Biosciences to develop University of Aberdeen’s RA compounds

Modern Biosciences Plc has signed an exclusive worldwide licensing agreement with the University of Aberdeen to develop a series of small molecule compounds for the treatment of rheumatoid arthritis (RA).